Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Castagna

Showing results (81-90 of 203) with videos related to

Pageof 21
Sort By:
Oncotarget|June 2, 2018
Donor lymphocyte infusions in adolescents and young adults for control of advanced pediatric sarcomaSebastian J Schober, Irene von Luettichau, Angela Wawer, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 16, 2010
Vertebroplasty for pain relief and spinal stabilization in multiple myelomaFlavio Tancioni, Martin Lorenzetti, Pierina Navarria, et al.
Leukemia & Lymphoma|March 1, 2012
Successful treatment of post-transplant Epstein-Barr virus-related meningoencephalitis by intravenous rituximab monotherapyRoberto Crocchiolo, Joseph Ciccolini, Jean El-Cheikh, et al.
Journal of Critical Care|July 22, 2015
Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen: Outcomes of patients admitted to intensive care unitDjamel Mokart, Angela Granata, Roberto Crocchiolo, et al.
Cancer|January 24, 2018
Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamideAnnalisa Ruggeri, Myriam Labopin, Andrea Bacigalupo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 29, 2012
Response to immunosuppressive treatment predicts outcome in patients with chronic graft-versus-host disease: a single-center analysis of longitudinal dataRoberto Crocchiolo, Colombe Saillard, Alessio Signori, et al.
Cancer Medicine|November 9, 2019
Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamideJacopo Mariotti, Daniela Taurino, Fabrizio Marino, et al.
Bone Marrow Transplantation|January 13, 2022
The association of graft-versus-leukemia effect and graft-versus host disease in haploidentical transplantation with post-transplant cyclophosphamide for AMLAvichai Shimoni, Myriam Labopin, Emanuele Angelucci, et al.
Transplantation and Cellular Therapy|April 15, 2021
Nonmyeloablative Conditioning Regimen Including Low-Dose Total Marrow/Lymphoid Irradiation Before Haploidentical Transplantation with Post-Transplantation Cyclophosphamide in Patients with Advanced Lymphoproliferative DiseasesBarbara Sarina, Pietro Mancosu, Pierina Navarria, et al.
Frontiers in Microbiology|January 20, 2025
The antibiotic de-escalation strategy in patients with multidrug-resistant bacterial colonization after allogeneic stem cell transplantationRoberto Bono, Giuseppe Sapienza, Stefania Tringali, et al.
Pageof 21

Showing results (81-90 of 203) with videos related to

Sort By:
Pageof 21
Oncotarget|June 2, 2018
Donor lymphocyte infusions in adolescents and young adults for control of advanced pediatric sarcomaSebastian J Schober, Irene von Luettichau, Angela Wawer, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 16, 2010
Vertebroplasty for pain relief and spinal stabilization in multiple myelomaFlavio Tancioni, Martin Lorenzetti, Pierina Navarria, et al.
Leukemia & Lymphoma|March 1, 2012
Successful treatment of post-transplant Epstein-Barr virus-related meningoencephalitis by intravenous rituximab monotherapyRoberto Crocchiolo, Joseph Ciccolini, Jean El-Cheikh, et al.
Journal of Critical Care|July 22, 2015
Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen: Outcomes of patients admitted to intensive care unitDjamel Mokart, Angela Granata, Roberto Crocchiolo, et al.
Cancer|January 24, 2018
Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamideAnnalisa Ruggeri, Myriam Labopin, Andrea Bacigalupo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 29, 2012
Response to immunosuppressive treatment predicts outcome in patients with chronic graft-versus-host disease: a single-center analysis of longitudinal dataRoberto Crocchiolo, Colombe Saillard, Alessio Signori, et al.
Cancer Medicine|November 9, 2019
Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamideJacopo Mariotti, Daniela Taurino, Fabrizio Marino, et al.
Bone Marrow Transplantation|January 13, 2022
The association of graft-versus-leukemia effect and graft-versus host disease in haploidentical transplantation with post-transplant cyclophosphamide for AMLAvichai Shimoni, Myriam Labopin, Emanuele Angelucci, et al.
Transplantation and Cellular Therapy|April 15, 2021
Nonmyeloablative Conditioning Regimen Including Low-Dose Total Marrow/Lymphoid Irradiation Before Haploidentical Transplantation with Post-Transplantation Cyclophosphamide in Patients with Advanced Lymphoproliferative DiseasesBarbara Sarina, Pietro Mancosu, Pierina Navarria, et al.
Frontiers in Microbiology|January 20, 2025
The antibiotic de-escalation strategy in patients with multidrug-resistant bacterial colonization after allogeneic stem cell transplantationRoberto Bono, Giuseppe Sapienza, Stefania Tringali, et al.
Pageof 21